Segment Reporting

12 Months Ended

Jan. 01, 2021

Segment Reporting [Abstract]

Segment Reporting

Note 17: Segment Reporting

The Company has two reportable operating segments based on two primary areas of service. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment.

Segment information is presented for selected data from the statements of income and statements of cash flows for 2020, 2019 and 2018. Segment information for selected data from the balance sheets is presented for the fiscal years ended January 1, 2021 and January 3, 2020. The Company’s CEO, the chief operating decision maker, does not review total assets in her evaluation of segment performance and capital allocation.

Revenues

	Fiscal Years
(In thousands)	2020		2019		2018
Engineering and Other Scientific	$	319,346	$	339,796	$	306,265
Environmental and Health		80,554		77,403		73,258
Total revenues	$	399,900	$	417,199	$	379,523

Operating Income

	Fiscal Years
(In thousands)	2020			2019			2018
Engineering and Other Scientific	$	100,616		$	110,822		$	100,307
Environmental and Health		26,728			26,589			23,824
Total segment operating income		127,344			137,411			124,131
Corporate operating expense		(44,095	)		(52,300	)		(32,675	)
Total operating income	$	83,249		$	85,111		$	91,456

Certain operating expenses are excluded from the Company's measure of segment operating income. These expenses include the costs associated with the Company’s human resources, finance, information technology, and business development groups; the deferred compensation expense/benefit due to the change in value of assets associated with the Company’s deferred compensation plan; stock-based compensation associated with restricted stock unit and stock option awards; and the change in the Company’s allowance for contract losses and doubtful accounts.

Capital Expenditures

	Fiscal Years
(In thousands)	2020		2019		2018
Engineering and Other Scientific	$	2,237	$	4,675	$	4,528
Environmental and Health		102		104		199
Total segment capital expenditures		2,339		4,779		4,727
Corporate capital expenditures		2,768		17,511		12,654
Total capital expenditures	$	5,107	$	22,290	$	17,381

Certain capital expenditures associated with the Company's corporate cost centers and the related depreciation are excluded from the Company's segment information. The high level of corporate capital expenditures during 2018 and 2019 was due to the land purchase and construction costs associated with the Company’s office and laboratory facilities in Natick, Massachusetts.

Depreciation and Amortization

	Fiscal Years
(In thousands)	2020		2019		2018
Engineering and Other Scientific	$	4,239	$	4,827	$	4,435
Environmental and Health		196		206		171
Total segment depreciation and amortization		4,435		5,033		4,606
Corporate depreciation and amortization		2,436		1,773		1,686
Total depreciation and amortization	$	6,871	$	6,806	$	6,292

Information regarding the Company’s operations in different geographical areas:

Property, Equipment and Leasehold Improvements, net

	Fiscal Years
(In thousands)	2020		2019
United States	$	58,900	$	60,074
Foreign Countries		923		1,513
Total	$	59,823	$	61,587

Revenues ⁽¹⁾

	Fiscal Years
(In thousands)	2020		2019		2018
United States	$	353,565	$	351,856	$	334,422
Foreign Countries		46,335		65,343		45,101
Total	$	399,900	$	417,199	$	379,523

⁽¹⁾ Geographic revenues are allocated based on the location of the client.

Below is a breakdown of goodwill, reported by segment as of January 1, 2021 and January 3, 2020:

(In thousands)	Environmental and Health		Engineering and Other Scientific		Total
Goodwill	$	8,099	$	508	$	8,607

There were no changes in the carrying amount of goodwill for 2020, 2019 and 2018. There were no goodwill impairments or gains or losses on disposals for any portion of the Company’s reporting units during 2020, 2019 and 2018.